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Stem cells in prostate regeneration and cancer
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Understanding the lineage relationship between normal progeni-
tor cells and cell type(s) of origin for cancer may yield important
molecular insights into prostate cancer prognosis and treatment
response. For example, several studies have suggested that the
prostate basal epithelial compartment contains stem/progenitor cells
that can be transformed to initiate cancers in tissue reconstitution
assays. In our work, we have shown that a known regulator of
prostate epithelial differentiation, the homeobox gene Nkx3.1, marks
a luminal stem cell population that functions during prostate
regeneration. Genetic lineage-tracing studies demonstrate that rare
cells which express Nkx3.1 in the absence of testicular androgens
(castration-resistant Nkx3.1-expressing cells, CARNs) are bipotential
and can self-renew in vivo, while single-cell transplantation assays
show that CARNs can reconstitute prostate ducts in renal grafts.
Targeted deletion of the Pten tumor suppressor gene in CARNs results
in rapid formation of carcinoma following androgen-mediated
regeneration. These observations indicate that CARNs represent a
novel luminal stem cell population that is an efficient target for
oncogenic transformation in prostate cancer. In our ongoing work, we
are investigating the properties of CARNs as well as other epithelial
cell types during prostate regeneration and as cells of origin for
cancer in vivo. In particular, we have utilized CK5-CreERT2 transgenic
mice for lineage-tracing of basal cells during androgen-mediated
prostate regeneration and oncogenic transformation. We will present
our recent findings and discuss their implications with respect to
elucidating the prostate epithelial lineage hierarchy and its relation-
ship to cancer initiation.
doi:10.1016/j.ydbio.2011.05.063
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In addition to its well-known role as a cellular chaperone, secreted
Hsp90 controls cell motility. However, the pathways that regulate
Hsp90 secretion remain largely unknown. Here we establish that the
previously uncharacterized E3 ubiquitin ligase Hectd1 regulates
secretion of Hsp90. Homozygous Hectd1 mutant mouse embryos
exhibit exencephaly, a type of neural tube defect that arises when the
anterior neural tube fails to close completely during embryonic
development. Exencephaly in Hectd1 mutants is associated with
disorganized and highly motile cranial mesenchyme. Our data
demonstrates in vivo that Hectd1-dependent K63-linked polyubiqui-
tination of Hsp90 regulates its secretion. In mutant cranial mesench-
yme cells, both secretion of Hsp90 and cell migration is enhanced.
Importantly, we show that this enhanced migration is highly
dependent on the excess Hsp90 secreted from mutant cells. Together
our data set forth a model where increased secretion of Hsp90 in the
cranial mesenchyme of Hectd1 mutant embryos is responsible, at
least in part, for the altered organization and migration of these cells
and provides a potential molecular mechanism underlying the neural
tube defect.
doi:10.1016/j.ydbio.2011.05.064
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Craniofrontonasal syndrome (CFNS) is a congenital condition
comprising multiple craniofacial developmental anomalies, including
cleft palate, and is caused by mutations in the X-linked EPHRIN-B1
(EFNB1) gene. Interestingly, females harboring heterozygous muta-
tion of EFNB1are more severely affected than hemizygous males, a
mysterious characteristic that is mirrored in mice with targeted null
mutation of efnb1. Efnb1 encodes a trans-membrane molecule that
can act by multiple distinct biochemical mechanisms either as a
ligand or a receptor to mediate cell-cell signaling. We have previously
shown that ephrin-B1 contributes to craniofacial development as a
ligand activating EphB receptor tyrosine kinase signaling. Here, we
show that ephrin-B1 promotes cell proliferation in the palatal
mesenchyme to drive outgrowth of the palatal shelves and control
their shape. Due to random X-inactivation, efnb1+/− heterozygotes
display mosaic disruption of ephrin-B1 expression domains. We find
that this mosaic disruption of ephrin-B1 expression boundaries leads
to a mosaic disruption of cell proliferation rate that correlates with
the more severe dysmorphogenesis of efnb1+/− heterozygotes that
is a hallmark of CFNS. Finally, we have identified the extracellular
signaling regulated kinase/mitogen activated protein kinase (ERK/
MAPK) signal transduction pathway as a key mediator of ephrin-B1-
driven morphogenesis. These findings provide mechanistic insight
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